Physician

Robert Anthony Equi, M.D.

According to 2025 Medicare claims, Robert Equi, M.D. (NPI: 1497864664) practices ophthalmology in the Sacramento-Roseville-Folsom, CA market, with the plurality of this provider's patient population coming from Sacramento, CA. This provider's primary affiliated billing organization is VITREO-RETINAL MEDICAL GROUP, INC. (NPI: 1942842984; TIN: 942442567) and primary practice location at 95825-5400. Equi is affiliated with the NeueHealth Premier ACO, LLC (ACO ID: D0181) and NeueHealth Community ACO, LLC (ACO ID: D0324), participating under the REACH model.

Equi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,364 traditional Medicare patients, billed 61,803 HCPCS/CPT codes, and received $2,996,072 in Medicare payments. The top billing code was 92235 (Exam of retinal blood vessels using a special camera after injection of a dye). Part D data shows 419 prescription claims across 180 beneficiaries totaling $15,808 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have declined steadily, from $35,119 to $15,808. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,965	20,897	$3,180,031
2016	1,948	20,929	$3,214,745
2017	1,814	19,329	$3,018,656
2018	1,758	17,032	$2,583,512
2019	1,847	16,506	$2,494,545
2020	1,632	13,214	$2,210,109
2021	1,739	14,760	$2,614,295
2022	1,601	14,731	$2,761,190
2023	1,457	35,896	$2,787,575
2024	1,364	61,803	$2,996,072

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	187	598	$35,119
2016	220	669	$33,813
2017	222	587	$37,586
2018	195	579	$26,706
2019	186	517	$29,179
2020	169	490	$30,912
2021	209	635	$32,160
2022	205	557	$30,710
2023	216	558	$26,170
2024	180	419	$15,808

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
92235	Exam of retinal blood vessels using a special camera after injection of a dye	301	346	$140
67028	Injection of drug into eye	403	1,422	$106
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	233	282	$99
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	1,039	1,964	$70
92134	Imaging of retina	1,262	2,902	$33

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Prednisolone Acetate	Prednisolone Acetate	129	5,303	$5,703
Ketorolac Tromethamine	Ketorolac Tromethamine	77	3,883	$2,231
Ofloxacin	Ofloxacin	77	1,507	$850
Brimonidine Tartrate	Brimonidine Tartrate	30	2,350	$468
Dorzolamide Hcl	Dorzolamide Hcl	22	1,467	$364

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Robert Anthony Equi, M.D.?

Tedicare shows public-source Medicare data for Robert Anthony Equi, M.D. (NPI 1497864664), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Robert Anthony Equi, M.D. have ACO affiliation data?

Robert Anthony Equi, M.D. is shown with ACO affiliation data for NeueHealth Premier ACO, LLC (REACH, ACO ID D0181) and NeueHealth Community ACO, LLC (REACH, ACO ID D0324).

What billing organization is linked to Robert Anthony Equi, M.D.?

Robert Anthony Equi, M.D. is linked to VITREO-RETINAL MEDICAL GROUP, INC. (billing NPI 1942842984) in the available physician profile data.

Does Robert Anthony Equi, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.